Tagged With MRNA

Moderna surges 11% after Trump says US government reached deal for 100 million doses of its coronavirus vaccine


Investors boosted their stock-market bets in May for the first time in 4 months, TD Ameritrade says


These are the 5 scientists and executives getting the richest off Moderna's spike to record highs



Moderna will spike another 25% from current levels after encouraging progress on coronavirus vaccine, Goldman says


Moderna skyrockets 29% after its early trial for a coronavirus vaccine produced antibodies in all 45 patients


Moderna skyrockets 16% to record high after FDA clears coronavirus vaccine for phase 2 study



A small group of scientists, execs, and VCs are $277 million richer as their companies race to create a coronavirus vaccine. Here are 7 who have raked in huge sums.


Coronavirus vaccine developer Moderna soared 30% as US stocks suffered their worst stretch in years. Here are the 10 investors that benefited most — and how much they made.


Hot biotech Moderna spikes 22% as it ships the first potential coronavirus vaccine for human testing


These 3 small pharmaceutical stocks are surging after announcing work on a coronavirus vaccine


Moderna Therapeutics, a biotech unicorn valued at more than $7.5 billion, could be gearing up for an IPO as early as this winter